Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-10

Clinical Trial Update: Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors [NA]

View source ↗

Summary

This is a clinical trial update assessing whether exercise improves quality of life for early-stage breast cancer patients on adjuvant aromatase inhibitors, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aromatase inhibitor (Aromatase inhibitor)
  • CDK4/6 inhibitor

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Early-stage Breast Cancer | NA | Status: NOT_YET_RECRUITING